A REVIEW OF CURRENT STEREOTACTIC ABLATIVE RADIOTHERAPY CLINICAL TRIALS FOR OLIGOMETASTATIC CANCERS

被引：0
|
作者：
Arifin, Andrew [1 ]
Al-Shafa, Faiez [1 ]
Rodrigues, George B. [1 ]
Palma, David A. [1 ]
Louie, Alexander V. [2 ]
机构：
[1] Western Univ, London, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [31] Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy
    Shor, D.
    Khoo, V.
    Jayaprakash, K. T.
    CLINICAL ONCOLOGY, 2024, 36 (07) : 402 - 405
  • [32] STEREOTACTIC ABLATIVE RADIOTHERAPY: A PROMISING CHANCE FOR OLIGOMETASTATIC BREAST CANCER PATIENTS
    Anselmo, Paola
    Arcidiacono, Fabio
    Casale, Michelina
    Nunzi, Martina
    Sabatini, Silvia
    Foglietta, Jenifer
    Italiani, Marco
    Trippa, Fabio
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S722 - S723
  • [33] Stereotactic Ablative Radiotherapy for Oligometastatic Disease: a Treatment in Search of Evidence - a Response
    Hargreaves, S.
    Comins, C.
    CLINICAL ONCOLOGY, 2016, 28 (08) : 503 - 504
  • [34] Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
    Correa, Rohann J. M.
    Palma, David A.
    LANCET ONCOLOGY, 2021, 22 (01): : 6 - 8
  • [35] Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence
    Macbeth, F.
    Treasure, T.
    CLINICAL ONCOLOGY, 2022, 34 (05) : 313 - 317
  • [36] Clinical trials of stereotactic ablative radiotherapy for prostate cancer: updates and future direction
    Musunuru, H. Bindu
    Loblaw, Andrew
    FUTURE ONCOLOGY, 2015, 11 (05) : 819 - 831
  • [37] Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
    David, Steven
    Tan, Jennifer
    Savas, Peter
    Bressel, Mathias
    Kelly, Dianne
    Foroudi, Farshad
    Loi, Sherene
    Siva, Shankar
    BREAST, 2020, 49 : 55 - 62
  • [38] Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
    Novikov, Sergey Nikolaevich
    Baldueva, Irina Aleksandrovna
    Zozulya, Anton Yurievich
    Emelyanova, Natalya Viktorovna
    Girdyuk, Dmitriy Viktorovich
    Arsenyev, Andrey Ivanovich
    Alexandrovna, Elena
    Tyuryaeva, Elena Ivanovna
    Antipov, E. I. Filip Evgenevich
    Girshovich, Mikhail Markovich
    Kanayev, Sergey Vasilevich
    RADIATION ONCOLOGY JOURNAL, 2023, 41 (01): : 23 - 31
  • [39] Tumor Control Probability Modeling and Systematic Review of Oligometastatic Prostate Cancer Treated with Stereotactic Ablative Radiotherapy
    Koerner, S. A.
    Wang, H.
    Olson, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E225 - E226
  • [40] Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis
    Lancia, Andrea
    Ingrosso, Gianluca
    Carosi, Alessandra
    Di Murro, Luana
    Giudice, Emilia
    Cicchetti, Sara
    Morelli, Pasquale
    di Cristino, Daniela
    Bruni, Claudia
    Murgia, Alessandra
    Cancelli, Alessandro
    Turturici, Irene
    Iadevaia, Anjali
    Ponti, Elisabetta
    Santoni, Riccardo
    ACTA ONCOLOGICA, 2017, 56 (11) : 1621 - 1625
12345